BrightEdge is the innovation, impact investment and venture capital arm of the American Cancer Society. Today, our ACS Impact Venture Fund (AIVF) invests in for-profit, early-stage companies developing cutting-edge, cancer-focused therapeutics, diagnostics, devices, and technologies to fuel and accelerate ACS’s mission of ending cancer as we know it, for everyone.
CapShift’s mission is to help financial and philanthropic institutions, along with their clients, mobilize capital for social and environmental change. To advance this mission, we partner with leading donor advised funds, national foundations, and private foundations to help them identify, access, and evaluate impact investments. Key funding and support from the Fink Family Foundation, Heron Foundation, and Omidyar Network helps us ensure that our activities align with our mission.
We are a nonprofit organization that aims to attack the wealth gaps in the United States while also ensuring the retiring small business owners can leave a legacy behind with the jobs they have created in their communities.
